H. Samonigg
Centre Léon Bérard · 135 works · 4,091 citations · h-index 30
Top works
- A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
- Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.
- Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]
- Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a
- Extended adjuvant treatment with anastrozole: Results from the Austrian Breast and Colorectal Cancer Study Group Trial 6a (ABCSG-6a)
- The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
- Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5
- A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
- Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
- The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
- Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
- Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
- In vivoconfocal laser scanning microscopy in the diagnosis of melanocytic skin tumours
- 4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)
- Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
- Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer
- In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images
- The impact of resection margins in the treatment of primary sarcomas of the breast. A clinicopathological study of 8 cases with review of literature.
- P81 Benefits of switching postmenopausal women withhormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3123 women enrolled in the ABCSG Trial 8 and the ARNO 95 Trial
- Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings